Therapies to Stimulate Remyelination
刺激髓鞘再生的疗法
基本信息
- 批准号:8935960
- 负责人:
- 金额:$ 21.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-30 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsAutoimmune ProcessBrainComplementDataDemyelinating DiseasesDemyelinationsDiseaseDrug FormulationsFamily PicornaviridaeGene ExpressionGenerationsGliosisGoalsGrowthHealthHistological TechniquesImmunologic TechniquesIn VitroInfectionKnowledgeLaboratoriesMediatingMicroRNAsMindMissionModelingMolecularMultiple SclerosisMusMyelinNerve DegenerationNerve TissueNeurogliaNeurologicNeuronsOligodendrogliaPatientsPilot ProjectsProductionPublic HealthPublicationsRegulatory PathwayResearchRoleSeverity of illnessSignal TransductionSmall RNASyndromeTMEVTestingTherapeuticTherapeutic EffectTimeTreatment EfficacyViralVisionbasedesignimprovedin vivomembermouse modelneuroprotectionpre-clinicalprogenitorrelating to nervous systemremyelinationrepairedsmall moleculestemtherapeutic miRNA
项目摘要
DESCRIPTION (provided by applicant): Although our knowledge about the formation of oligodendrocytes and their progenitors has grown enormously during the past two decades, the formulation of specific therapies to promote remyelination in patients with myelin diseases such as multiple sclerosis (MS) is still far from realization. An ideal therapy would include the use of
small molecules to specifically activate the production of oligodendrocyte progenitors and remyelinating oligodendrocytes during a period of time sufficiently long to allow myelin repair. This therapy should then be controllable (i.e. therapists should be able to turn on/off the production of remyelinating oligodendrocytes to promote the right level of neural repair). With this conceptual vision of therapies for remyelination in mind, the goal of this pilot application i to obtain proof-of-concept that a set of microRNA can be used to improve remyelination in a mouse model of MS. MicroRNA (miR) are small RNA molecules which exert profound regulatory control of gene expression at the post-transcriptional level. miR-138, -219 and -338 and also members of the miR cluster 17-92 appear to positively control oligodendrocyte differentiation. Preliminary data for this application show that some of these microRNA are downregulated in the Theiler's murine encephalomyelitis virus (TMEV) model of MS. This application will challenge the hypothesis that reverting the deficiency of pro-oligodendrocyte miR in TMEV-infected mice by exogenous administration of synthetic miR (complementation therapy) will improve remyelination by increasing numbers of functional myelinating oligodendrocytes. The project is significant because it is expected to advance the understanding of how miR regulate remyelination in vivo, particularly in a model of MS. Ultimately, such understanding has the potential to contribute to improve existing immunomodulatory therapies for MS.
描述(由申请人提供):尽管我们关于少突胶质细胞及其祖细胞形成的知识在过去二十年中有了巨大的增长,但促进髓鞘疾病如多发性硬化症(MS)患者髓鞘再生的特异性疗法的制定仍远未实现。理想的治疗方法包括使用
小分子以在足够长的时间段内特异性激活少突胶质细胞祖细胞和髓鞘再生少突胶质细胞的产生,以允许髓鞘修复。这种治疗应该是可控的(即治疗师应该能够打开/关闭髓鞘再生少突胶质细胞的产生,以促进神经修复的正确水平)。考虑到髓鞘再生疗法的这种概念性视野,该试验性应用的目标是获得一组微小RNA可用于改善MS小鼠模型中的髓鞘再生的概念验证。微小RNA(miR)是在转录后水平对基因表达施加深刻调控控制的小RNA分子。miR-138、-219和-338以及miR簇17-92的成员似乎正控制少突胶质细胞分化。本申请的初步数据显示,这些微RNA中的一些在MS的Theiler小鼠脑脊髓炎病毒(TMEV)模型中下调。本申请将挑战以下假设:通过外源性施用合成miR(互补疗法)来恢复TMEV感染的小鼠中的前少突胶质细胞miR的缺乏将通过增加功能性髓鞘生成少突胶质细胞的数量来改善髓鞘再生。该项目意义重大,因为它有望促进对miR如何调节体内髓鞘再生的理解,特别是在MS模型中。最终,这种理解有可能有助于改善MS的现有免疫调节疗法。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A microglial hypothesis of globoid cell leukodystrophy pathology.
- DOI:10.1002/jnr.23773
- 发表时间:2016-11
- 期刊:
- 影响因子:4.2
- 作者:Nicaise, Alexandra M.;Bongarzone, Ernesto R.;Crocker, Stephen J.
- 通讯作者:Crocker, Stephen J.
Port-to-port delivery: Mobilization of toxic sphingolipids via extracellular vesicles.
- DOI:10.1002/jnr.23798
- 发表时间:2016-11
- 期刊:
- 影响因子:4.2
- 作者:Scesa, Giuseppe;Moyano, Ana Lis;Bongarzone, Ernesto R.;Givogri, Maria I.
- 通讯作者:Givogri, Maria I.
Recent progress on lipid lateral heterogeneity in plasma membranes: From rafts to submicrometric domains.
- DOI:10.1016/j.plipres.2015.12.004
- 发表时间:2016-04
- 期刊:
- 影响因子:13.6
- 作者:Carquin M;D'Auria L;Pollet H;Bongarzone ER;Tyteca D
- 通讯作者:Tyteca D
Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies.
- DOI:10.1002/jnr.23751
- 发表时间:2016-11
- 期刊:
- 影响因子:4.2
- 作者:Marshall, Michael S.;Bongarzone, Ernesto R.
- 通讯作者:Bongarzone, Ernesto R.
Fluid levity of the cell: Role of membrane lipid architecture in genetic sphingolipidoses.
- DOI:10.1002/jnr.23750
- 发表时间:2016-11
- 期刊:
- 影响因子:4.2
- 作者:D'Auria, Ludovic;Bongarzone, Ernesto R.
- 通讯作者:Bongarzone, Ernesto R.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ernesto Roque Bongarzone其他文献
Ernesto Roque Bongarzone的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ernesto Roque Bongarzone', 18)}}的其他基金
CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease
CGT 和 ACD 抑制剂用于 SRT 治疗克拉伯病
- 批准号:
10708106 - 财政年份:2022
- 资助金额:
$ 21.8万 - 项目类别:
CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease
CGT 和 ACD 抑制剂用于 SRT 治疗克拉伯病
- 批准号:
10581356 - 财政年份:2022
- 资助金额:
$ 21.8万 - 项目类别:
Combined neuroprotection and metabolic correction to treat leukodystrophies
联合神经保护和代谢校正治疗脑白质营养不良
- 批准号:
8321032 - 财政年份:2009
- 资助金额:
$ 21.8万 - 项目类别:
Combined Neuroprotection and Metabolic Correction to Treat Leukodystrophies
联合神经保护和代谢校正治疗脑白质营养不良
- 批准号:
9333446 - 财政年份:2009
- 资助金额:
$ 21.8万 - 项目类别:
Combined neuroprotection and metabolic correction to treat leukodystrophies
联合神经保护和代谢校正治疗脑白质营养不良
- 批准号:
8525467 - 财政年份:2009
- 资助金额:
$ 21.8万 - 项目类别:
Combined neuroprotection and metabolic correction to treat leukodystrophies
联合神经保护和代谢校正治疗脑白质营养不良
- 批准号:
7792796 - 财政年份:2009
- 资助金额:
$ 21.8万 - 项目类别:
Combined neuroprotection and metabolic correction to treat leukodystrophies
联合神经保护和代谢校正治疗脑白质营养不良
- 批准号:
8131096 - 财政年份:2009
- 资助金额:
$ 21.8万 - 项目类别:
Combined Neuroprotection and Metabolic Correction to Treat Leukodystrophies
联合神经保护和代谢校正治疗脑白质营养不良
- 批准号:
9028056 - 财政年份:2009
- 资助金额:
$ 21.8万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 21.8万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 21.8万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 21.8万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 21.8万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)